Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
Saved in:
| Title: | Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study. |
|---|---|
| Authors: | Mamakou V; Medical School, National and Kapodistrian University Athens, 75 M. Assias Street, 115 27, Athens, Greece. vmamakou@hotmail.com.; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece. vmamakou@hotmail.com., Hackinger S; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK., Zengini E; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Tsompanaki E; School of Information Sciences and Technology, Department of Statistics, Athens University of Economics and Business, 10434, Athens, Greece., Marouli E; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, EC1M 6BQ, London, UK., Serafetinidis I; Department of Gastroenterology, Gennimatas General Hospital, 11527, Athens, Greece., Prins B; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK., Karabela A; Dafni Psychiatric Hospital, 12462, Athens, Greece., Glezou E; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece., Southam L; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Rayner NW; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, UK., Kuchenbaecker K; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK., Lamnissou K; National and Kapodistrian University of Athens, Department of Biology, Athens, Panepistimioupolis, AnoIlisia, 15771, Athens, Greece., Kontaxakis V; Early Psychosis Unit, 1st Department of Psychiatry, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece., Dedoussis G; Department of Nutrition-Dietetics, Harokopio University, 17671, Athens, Greece., Gonidakis F; 1st Psychiatric Department, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece., Thanopoulou A; Diabetes Centre, 2nd Department of Internal Medicine, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece., Tentolouris N; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Medical School, Laiko General Hospital, 11527, Athens, Greece., Zeggini E; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK. |
| Source: | BMC psychiatry [BMC Psychiatry] 2018 Aug 02; Vol. 18 (1), pp. 249. Date of Electronic Publication: 2018 Aug 02. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30071838 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mamakou+V%22">Mamakou V</searchLink>; Medical School, National and Kapodistrian University Athens, 75 M. Assias Street, 115 27, Athens, Greece. vmamakou@hotmail.com.; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece. vmamakou@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Hackinger+S%22">Hackinger S</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.<br /><searchLink fieldCode="AU" term="%22Zengini+E%22">Zengini E</searchLink>; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Tsompanaki+E%22">Tsompanaki E</searchLink>; School of Information Sciences and Technology, Department of Statistics, Athens University of Economics and Business, 10434, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Marouli+E%22">Marouli E</searchLink>; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, EC1M 6BQ, London, UK.<br /><searchLink fieldCode="AU" term="%22Serafetinidis+I%22">Serafetinidis I</searchLink>; Department of Gastroenterology, Gennimatas General Hospital, 11527, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Prins+B%22">Prins B</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.<br /><searchLink fieldCode="AU" term="%22Karabela+A%22">Karabela A</searchLink>; Dafni Psychiatric Hospital, 12462, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Glezou+E%22">Glezou E</searchLink>; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Southam+L%22">Southam L</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Rayner+NW%22">Rayner NW</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kuchenbaecker+K%22">Kuchenbaecker K</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.<br /><searchLink fieldCode="AU" term="%22Lamnissou+K%22">Lamnissou K</searchLink>; National and Kapodistrian University of Athens, Department of Biology, Athens, Panepistimioupolis, AnoIlisia, 15771, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Kontaxakis+V%22">Kontaxakis V</searchLink>; Early Psychosis Unit, 1st Department of Psychiatry, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Dedoussis+G%22">Dedoussis G</searchLink>; Department of Nutrition-Dietetics, Harokopio University, 17671, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Gonidakis+F%22">Gonidakis F</searchLink>; 1st Psychiatric Department, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Thanopoulou+A%22">Thanopoulou A</searchLink>; Diabetes Centre, 2nd Department of Internal Medicine, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Tentolouris+N%22">Tentolouris N</searchLink>; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Medical School, Laiko General Hospital, 11527, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Zeggini+E%22">Zeggini E</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100968559%22">BMC psychiatry</searchLink> [BMC Psychiatry] 2018 Aug 02; Vol. 18 (1), pp. 249. <i>Date of Electronic Publication: </i>2018 Aug 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968559 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-244X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221471244X%22">1471244X </searchLink><i>NLM ISO Abbreviation: </i>BMC Psychiatry <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30071838 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12888-018-1826-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 249 Titles: – TitleFull: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mamakou V – PersonEntity: Name: NameFull: Hackinger S – PersonEntity: Name: NameFull: Zengini E – PersonEntity: Name: NameFull: Tsompanaki E – PersonEntity: Name: NameFull: Marouli E – PersonEntity: Name: NameFull: Serafetinidis I – PersonEntity: Name: NameFull: Prins B – PersonEntity: Name: NameFull: Karabela A – PersonEntity: Name: NameFull: Glezou E – PersonEntity: Name: NameFull: Southam L – PersonEntity: Name: NameFull: Rayner NW – PersonEntity: Name: NameFull: Kuchenbaecker K – PersonEntity: Name: NameFull: Lamnissou K – PersonEntity: Name: NameFull: Kontaxakis V – PersonEntity: Name: NameFull: Dedoussis G – PersonEntity: Name: NameFull: Gonidakis F – PersonEntity: Name: NameFull: Thanopoulou A – PersonEntity: Name: NameFull: Tentolouris N – PersonEntity: Name: NameFull: Zeggini E IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 08 Text: 2018 Aug 02 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1471-244X Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: BMC psychiatry Type: main |
| ResultId | 1 |